1 g of hydrocortisone acetate 5 mg. Excipients: nipagin (methylparahydroxybenzoate or methylparaben), petrolatum.
GKS for local use in ophthalmology. It has anti-inflammatory and anti-allergic effect. Reduces inflammatory cellular infiltrates, reduces the migration of white blood cells and lymphocytes in the area of inflammation.
Data on the pharmacokinetics of the drug is not provided.
- inflammation of the anterior part of the eye with undisturbed corneal epithelium (injuries and surgical interventions on the eyeball) - sympathetic ophthalmia - conjunctivitis - blepharitis - iritis - iridocyclitis - keratitis - uveitis - inflammation on the background of chemical and physical influences.
- vaccination period - viral, fungal and infectious eye lesions - violation of the integrity of the ocular epithelium - trachoma - eye tuberculosis - hypersensitivity to the drug components. With caution should use the drug for hypertension, diabetes, pregnancy, during lactation.
Use during pregnancy and lactation
The use of the drug during pregnancy is possible only in the case when the intended benefits to the mother outweigh the potential risk to the fetus. Take the drug during pregnancy is recommended no more than 7-10 days. If necessary, the use of the drug during lactation should decide on the termination of breastfeeding.
Dosage and administration
In the conjunctival sac injected 1-2 cm eye ointment 2-3 times / day.
On the part of the organ of vision: burning, sclera injection; with prolonged use - posterior subcapsular cataract, increased intraocular pressure, exophthalmos, a tendency to develop a secondary fungal, bacterial or viral infection of the eye, trophic changes of the cornea.
So far, cases of overdose have been observed.
Interaction with other drugs
The risk of developing cataracts increases when antipsychotics (neuroleptics), carbutamide, and azathioprine are used against the background of SCS. Simultaneous use of GCS with anticholinergics (includingantihistamines, tricyclic antidepressants) and nitrates promotes an increase in intraocular pressure.
During treatment with the drug should not use contact lenses. When using eye drops, the time interval between their application and application of ointment is at least 15 minutes. When applying the ointment for more than 2 weeks and with a history of glaucoma, intraocular pressure should be monitored. Influence on the ability to drive motor vehicles and control mechanisms For 30 minutes after applying the ointment, you must refrain from activities that require increased attention.